0.3700
+0.0090
+(2.49%)
At close: January 10 at 3:00:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 48 | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.71 per share. | Indirect | 51,741 | Nov 8, 2023 |
| JACOB JEFFREY E Director | -- | Indirect | -- | Sep 12, 2023 |
| HORVATH SUSAN Chief Financial Officer | -- | Direct | -- | Jan 30, 2023 |
| SIMPSON JENNIFER K Chief Executive Officer | -- | Direct | -- | Jan 30, 2023 |
Related Tickers
ENTO Entero Therapeutics, Inc.
0.5899
-4.85%
NEXI NexImmune, Inc.
0.1000
0.00%
DRMA Dermata Therapeutics, Inc.
1.2000
-4.76%
ABVC ABVC BioPharma, Inc.
0.5540
+3.75%
AZTR Azitra, Inc.
0.3600
-8.30%
TSOI Therapeutic Solutions International, Inc.
0.0002
-33.33%
ENDV Endonovo Therapeutics, Inc.
0.0004
0.00%
MOLN Molecular Partners AG
4.9837
-5.97%
ERNA Eterna Therapeutics Inc.
0.3000
-7.21%
LIXT Lixte Biotechnology Holdings, Inc.
2.5900
+12.61%